DADC
ANIP icon

D.A. Davidson & Co’s ANI Pharmaceuticals ANIP Stock Holding History

D.A. Davidson & Co’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27
Closed -$1K – 2208
2015
Q3 		$1K Hold
27
– – ﹤0.01% 2128
2015
Q2 		$1K Hold
27
– – ﹤0.01% 2152
2015
Q1 		$1K Hold
27
– – ﹤0.01% 2032
2014
Q4 		$1K Hold
27
– – ﹤0.01% 2055
2014
Q3 		$0 Hold
27
– – ﹤0.01% 2096
2014
Q2 		$0 Hold
27
– – ﹤0.01% 2088
2014
Q1 		$0 Hold
27
– – ﹤0.01% 2095
2013
Q4 		$0 Hold
27
– – ﹤0.01% 2041
2013
Q3 		$0 Sell
27
-1
-4% -$7 ﹤0.01% 1729
2013
Q2 		$0 Buy
+28
New +$196 ﹤0.01% 1681

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.A. Davidson & Co's ANIP Position: Q4 2015 in Review

D.A. Davidson & Co sold out of ANI Pharmaceuticals (ANIP) in Q4 2015, closing a stake of 27 shares — an estimated $1K sold.

D.A. Davidson & Co first reported a position in ANIP in Q2 2013 and held it in 10 quarters. The position peaked at $1K in Q3 2015. 123 funds tracked by Wall St. Rank hold ANIP as of Q4 2015.

  • D.A. Davidson & Co reported no remaining ANI Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • D.A. Davidson & Co sold 27 ANI Pharmaceuticals shares in Q4 2015, an estimated $1K.
  • D.A. Davidson & Co first reported a position in ANI Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • D.A. Davidson & Co's ANI Pharmaceuticals position peaked at $1K in Q3 2015.
  • 123 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2015.

Based on D.A. Davidson & Co's 13F filing for Q4 2015, filed 12 Feb 2016.